COLORADO DENVER UNIVERSITY OF

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Treatment of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil-1

Phase 1

Completed

Conditions: Pulmonary Hypertension
COPD

Interventions: Drug: Inhaled Treprostinil Therapy

First Posted Date: 2013-01-01

Last Posted Date: 2016-07-20

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 10

Registration Number: NCT01758744

Locations: 🇺🇸
University of Florida College of Medicine, Jacksonville, Florida, United States
🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

Predicting Lung Injury From Transfusion in Patients With Liver Disease

Terminated

Conditions: Transfusion-related Acute Lung Injury
Gastrointestinal Bleeding
Chronic Liver Disease

First Posted Date: 2012-12-27

Last Posted Date: 2017-01-30

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 16

Registration Number: NCT01756690

Locations: 🇺🇸
University of Colorado Denver, Anshutz medical campus, Aurora, Colorado, United States
🇺🇸
Denver Health and Hospital, Denver, Colorado, United States

Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder

Phase 2

Completed

Conditions: Insomnia
Autism Spectrum Disorder

Interventions: Drug: Ferrous sulfate
Drug: Placebo

First Posted Date: 2012-12-10

Last Posted Date: 2020-08-03

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 24

Registration Number: NCT01745497

Locations: 🇨🇦
The Hospital for Sick Children, Toronto, Ontario, Canada
🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
🇺🇸
Childrens Hospital Colorado, Aurora, Colorado, United States

and more 1 locations

Azacitidine and Lenalidomide for Relapsed and Refractory Patients With Acute Myeloid Leukemia

Phase 2

Completed

Conditions: Acute Myeloid Leukemia

Interventions: Drug: Azacitidine
Drug: Lenalidomide
Other: Off Therapy

First Posted Date: 2012-12-06

Last Posted Date: 2019-10-08

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 37

Registration Number: NCT01743859

Locations: 🇺🇸
University of Colorado Cancer Center, Aurora, Colorado, United States

Adolescent Vaccination Reminder Study

Not Applicable

Completed

Conditions: Adolescent Vaccination Status

Interventions: Behavioral: Email Notification

First Posted Date: 2012-11-22

Last Posted Date: 2015-08-17

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 3783

Registration Number: NCT01732315

Locations: 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States

Treatment for Children With Autism and Anxiety

Not Applicable

Completed

Conditions: Autism

Interventions: Behavioral: Facing Your Fears

First Posted Date: 2012-11-16

Last Posted Date: 2012-11-16

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 50

Registration Number: NCT01727466

Genetic Studies in Patients and Families With Infantile Spasms

Completed

Conditions: Infantile Spasms

First Posted Date: 2012-11-08

Last Posted Date: 2021-06-14

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 63

Registration Number: NCT01723787

Locations: 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States

School Located Adolescent Vaccination Study

Not Applicable

Completed

Conditions: School Located Vaccine Program

Interventions: Behavioral: School Located Vaccine (SLV) Program

First Posted Date: 2012-11-01

Last Posted Date: 2013-01-03

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 2000

Registration Number: NCT01719679

Locations: 🇺🇸
Kaiser Permanente Colorado, Denver, Colorado, United States
🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

Role of Macronutrient Diet Composition and Infant Metabolic Outcomes in Gestational Diabetes

Not Applicable

Completed

Conditions: Gestational Diabetes Mellitus

Interventions: Other: High Carbohydrate/Low fat diet
Other: Low-Carbohydrate/Higher Fat Diet

First Posted Date: 2012-11-01

Last Posted Date: 2015-06-10

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 35

Registration Number: NCT01719029

Locations: 🇺🇸
University of Colorado, Anschutz Medical Campus, Aurora, Colorado, United States

An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia

Phase 4

Completed

Conditions: Friedreich Ataxia

Interventions: Drug: Bupropion & Placebo
Drug: Placebo & Placebo
Drug: bupropion & Citalopram
Drug: Placebo & Citalopram

First Posted Date: 2012-10-29

Last Posted Date: 2016-09-19

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 1

Registration Number: NCT01716221

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy